Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
Objective. To report long-term safety and tolerability of olokizumab (OKZ) in combination with methotrexate (MTX) in subjects with active rheumatoid arthritis (RA), using pooled data from three randomised clinical trials (RCT) followed by open-label extension (OLE) study.Methods. Cumulative data fro...
| Autori principali: | , , , , , , , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | Russian |
| Pubblicazione: |
IMA-PRESS LLC
2024-12-01
|
| Serie: | Современная ревматология |
| Accesso online: | https://mrj.ima-press.net/mrj/article/view/1663 |